These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 18187317)

  • 1. Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.
    Akbani R; Becker KF; Carragher N; Goldstein T; de Koning L; Korf U; Liotta L; Mills GB; Nishizuka SS; Pawlak M; Petricoin EF; Pollard HB; Serrels B; Zhu J
    Mol Cell Proteomics; 2014 Jul; 13(7):1625-43. PubMed ID: 24777629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular marker identification for relapse prediction in 5-FU-based adjuvant chemotherapy in gastric and colorectal cancers.
    Ishida K; Nishizuka SS; Chiba T; Ikeda M; Kume K; Endo F; Katagiri H; Matsuo T; Noda H; Iwaya T; Yamada N; Fujiwara H; Takahashi M; Itabashi T; Uesugi N; Maesawa C; Tamura G; Sugai T; Otsuka K; Koeda K; Wakabayashi G
    PLoS One; 2012; 7(8):e43236. PubMed ID: 22905237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse-phase protein lysate microarray (RPA) for the experimental validation of quantitative protein network models.
    Nishizuka SS
    Methods Mol Biol; 2011; 785():65-77. PubMed ID: 21901594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of quantitative proteomic analysis for cancer therapy using "reverse-phase" protein lysate microarrays].
    Nishizuka S; Spurrier B; Honkanen P; Austin J; Wakabayashi G
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):200-5. PubMed ID: 18281757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse-phase protein lysate microarrays for cell signaling analysis.
    Spurrier B; Ramalingam S; Nishizuka S
    Nat Protoc; 2008; 3(11):1796-808. PubMed ID: 18974738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental validation for quantitative protein network models.
    Nishizuka S; Spurrier B
    Curr Opin Biotechnol; 2008 Feb; 19(1):41-9. PubMed ID: 18187317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse-phase protein microarrays: application to biomarker discovery and translational medicine.
    VanMeter A; Signore M; Pierobon M; Espina V; Liotta LA; Petricoin EF
    Expert Rev Mol Diagn; 2007 Sep; 7(5):625-33. PubMed ID: 17892368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein microarrays as tools for functional proteomics.
    LaBaer J; Ramachandran N
    Curr Opin Chem Biol; 2005 Feb; 9(1):14-9. PubMed ID: 15701447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein and lysate array technologies in cancer research.
    Spurrier B; Honkanen P; Holway A; Kumamoto K; Terashima M; Takenoshita S; Wakabayashi G; Austin J; Nishizuka S
    Biotechnol Adv; 2008; 26(4):361-9. PubMed ID: 18514460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human protein atlas and the use of microarray technologies.
    Hober S; Uhlén M
    Curr Opin Biotechnol; 2008 Feb; 19(1):30-5. PubMed ID: 18187316
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.